---
title: "GNLX.US (GNLX.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/GNLX.US/news.md"
symbol: "GNLX.US"
name: "GNLX.US"
parent: "https://longbridge.com/zh-CN/quote/GNLX.US.md"
datetime: "2026-03-13T21:02:00.114Z"
locales:
  - [en](https://longbridge.com/en/quote/GNLX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GNLX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GNLX.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/GNLX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/GNLX.US/news.md)


# GNLX.US (GNLX.US) — 相关新闻

### [Genelux (NASDAQ:GNLX)  Shares Down 2.7%   - Should You Sell?](https://longbridge.com/zh-CN/news/277147482.md)
*2026-02-27T05:53:26.000Z*
> Genelux Corporation (NASDAQ:GNLX) shares fell 2.7% to $2.89 during mid-day trading, with a trading volume decline of 30%

### [GenFlux Raises $4.2M as Brands Race to Own the AI Answer](https://longbridge.com/zh-CN/news/275537447.md)
*2026-02-11T01:53:10.000Z*
> GenFlux, a platform focused on helping brands optimize their visibility in AI-generated answers, has raised $4.2 million

### [GenFlux secures $4.2M in funding to help brands manage their AI-generated responses. Symbolic Capital leads the round.](https://longbridge.com/zh-CN/news/275538406.md)
*2026-02-11T01:46:35.000Z*
> A Denver-based company, GenFlux, revealed that they have secured $4.2 million in seed funding from Symbolic Capital, Bor

### [FDA grants full approval of a drug to control seizures in dogs with idiopathic epilepsy](https://longbridge.com/zh-CN/news/273271788.md)
*2026-01-21T19:16:20.000Z*
> FDA grants full approval of a drug to control seizures in dogs with idiopathic epilepsy

### [Genelux Executives Join Titan Partners for Virtual Fireside Chat](https://longbridge.com/zh-CN/news/272317333.md)
*2026-01-12T21:00:10.000Z*
### [Genelux Corporation plans a public offering of common stock on Nasdaq (GNLX). Underwriter may have option for 15% more. Market conditions can affect completion.](https://longbridge.com/zh-CN/news/272128416.md)
*2026-01-09T22:01:30.000Z*
> Genelux Corporation, a late clinical-stage immuno-oncology company, has announced a proposed underwritten public offerin

### [Weekly Buzz: ScinoPharm Gets FDA Nod; GNLX's Olvi-Vec Shows Promise; GLUE's MRT-8102 Advances](https://longbridge.com/zh-CN/news/272078344.md)
*2026-01-09T12:58:52.000Z*
> The biotech sector saw significant developments this week, highlighted by ScinoPharm's FDA approval for Glatiramer Aceta

### [Genelux Corp Announces $20 Million Public Offering](https://longbridge.com/zh-CN/news/271991063.md)
*2026-01-08T22:13:00.000Z*
> Genelux Corporation has announced a $20 million public offering of common stock, pricing 6,666,667 shares at $3.00 each.

### [Genelux announces a $20M public offering of 6,666,667 shares priced at $3.00 each. All shares sold by the company.](https://longbridge.com/zh-CN/news/271950127.md)
*2026-01-08T14:15:12.000Z*
> Genelux Corporation, a late clinical-stage immuno-oncology company based in Westlake Village, California, has disclosed